BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 4:56:00 PM | Browse: 1261 | Download: 1651
 |
Received |
|
2012-12-20 01:56 |
|
Peer-Review Started |
|
2012-12-20 14:46 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2012-12-28 16:59 |
|
Revised |
|
2013-01-09 23:51 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-01-23 16:52 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-01-24 07:46 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-02-25 14:43 |
|
Publish the Manuscript Online |
|
2013-03-01 15:37 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Guan-Min Lai, Sheng-Lei Yan, Cheng-Shyong Chang and Chien-Yu Tsai |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Cheng-Shyong Chang, MD, Division of Hemato-Oncology, Department of Internal Medicine, Changhua Christian Hospital, Changhua 500, Taiwan. 15120@cch.org.tw
|
| Key Words |
Hepatitis B virus; Chronic myeloid leukemia; Imatinib mesylate; Nilotinib; Tyrosine kinase inhibitor |
| Core Tip |
|
| Publish Date |
2013-03-01 15:37 |
| Citation |
Lai GM, Yan SL, Chang CS, Tsai CY. Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor. World J Gastroenterol 2013; 19(8): 1318-1321
|
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i8/1318.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i8.1318 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
